The Science Behind the Scandal Ozone Therapy: The Science Behind the Scandal. AIDS NEWS SERVICE.
Michael Howe, MSLS, Editor. AIDS Information Center. VA Medical Center, San Francisco. April 1. 5, 1. 99. OZONE THERAPY (Part I). Medical Ozone Products. Welcome to the product page! These products have been tested and are known to work well in conjunction with oxygen therapies, there are also links to training, books, videos and other merchandise that. Oxygen OXYGEN, OZONE, & HYDROGEN PEROXIDE Majid Ali, M.D. Natural News launches 'miracle' Ozone Dentistry product for gum care: O3 Essentials OraJuvenate. Oxymed Hospital offers a unique treatment method, called EECP, Chelation and Ozone Therapy, which is not only a non surgical treatment Breakthrough in human cell transformation could revolutionize regenerative medicine Date: January 19, 2016 Source: University of Bristol Summary: A breakthrough in the transformation of human cells by an international team of. Medical Ozone and Cancer Medical Ozone Saves Lives in Europe, but the FDA continues to Prevent Formal Testing in the USA. Ozone therapy, involving doses of the reactive oxygen gas. Europe a popular alternative treatment for a. Oct 4; 1. 59(7): 4. The daily dose of ozone. O3) ranged from 2. Three of the four patients whose. The fifth. patient, whose diarrhea was due to Cryptosporidium, experienced. No consistent change in the absolute number of helper. CD4) or suppressor (CD8) lymphocytes was detected, and no. PO2 or the results of routine. Patients had mild to. The results of this series suggest that medical ozone. Should this simple treatment be used routinely to. ARC/AIDS diarrhea? METHODS AND. PATIENTS: The therapeutic regimen comprised autologous ozone. No. conventional antiviral therapy was given. Patients (all male. Gr. I- V) according to. CD4 lymphocyte counts at entry into therapy (Gr. I n = 2. 2. CD4 0- 5. Gr. II n = 1. 2, CD4 5. Gr. III n = 1. 7, CD4 1. Gr. IV n = 8. 1, CD4 2. Gr. V n = 5. 3, CD4 greater than. IV and V 6. months). RESULTS: Patients in Gr. I presented a median loss of. CD4 lymphocytes per month of 0. Gr. II median loss 3. Gr. III median loss 4. V, apparently due to the. IV, with. an approved indication for antiviral therapy, presented a median. CD4- cells of 4. 4. IV exceeded these values, while 2. No substantial adverse events or side effects accompanied. QOL generally increased. Further investigation including controlled. Pittman, a physician in. Raleigh, N. C., discontinued his ozone gas therapy for AIDS. North Carolina Board of Medical Examiners. Oct; 1. 6(3): 2. 81- . The inactivation of human immunodeficiency virus (HIV) and. The titer of HIV suspensions. Complete inactivation of HIV. H- 9 cells. In contrast, cellular. MTT dye cleavage, and DNA. BUd. R incorporation, were enhanced in. H- 9 cells grown in media treated with quantities of ozone that. HIV. Ozone was found to. HIV- 1 virions in a dose- dependent manner. Greater. than 1. 1 log inactivation was achieved within 2 hours at a. Similar concentrations of. VIII activity in both plasma. VIII treated. for the same time period. The data indicate that the antiviral. Ozone. treatment offers promise as a means to inactivate human. We performed. a phase I study of ozone blood treatments in 1. Three patients with. HIV- associated immune disease. A phase II controlled. Ozone had no significant effect on hematologic. CD4. cell count, interleukin- 2, gamma- interferon, beta 2- . In conclusion, ozone therapy does not. HIV- infected individuals. Mar; 6. 2(3): 1. 94- 7. Jan; 9. 4(1): 5. 0- 1. In traumatic surgery allogeneic bone. This technique has been abandoned since the. HIV. In an experimental. HIV in bone for transplantation. Jun 4- 9; 5: 6. 56 (abstract no. METHODS: Heparinized whole blood. Coded, blinded blood samples were. RESULTS: 0. 3 had no effect on lymphocyte populations. T cells, CD4, CD8. B cell subpopulations did not change. In contrast, there. HIV. positive donor with increasing (0. CONCLUSIONS: Ozone, at. HIV1, may alter. lymphocyte surface markers in HIV1 infected patients. Further. studies are indicated to examine this effect. At present Medizone International Inc. Medizone Canada Ltd are awaiting US Food and Drug. Administration and Canadian Health and Welfare approval. Medizone (R) (ozone/oxygen) drug in the treatment of. Acquired Immune Deficiency Syndrome (AIDS). The following is a. Medizone International Inc's research to date. To date, treatment only affords temporary suppression. In Europe, one modality. The mixture is. introduced into fixed volumes of the patient's blood 'ex vivo'. However, in view of the fact that no controlled. A series of studies were undertaken to. Medizone(R)) mixture in a variety of animal models (toxicity. Medizone(R)) on a. HIV target cell line, HUT- 7. Medizone(R)) on. HIV 'in vitro'. Medizone(R)) in human peripheral. Medizone(R)) on exogenously HIV- 1. Factor VIII preparations. These studies were performed at the State. University of New York at Syracuse under the auspices of Dr. Bernard Poiesz. These studies were performed. Mount Sinai School of Medicine in New York, under the. Dr Michael Greenburg. Medizone(R) of Factor VIII preparations. HIV- 1 yielded a minimum (ten) log. Those. viruses which are lipid- encapsulated (ie. Investigations with Rhodamine- labelled HIV. HIV virions, have suggested. This data suggests that ozone. HIV's ability to bind to CA4. A +. target cells. In particular, superoxide distumase (SOD). CAT) and glutathione peroxidase (GSHPx) levels are. Such. decreases may render these cells selectively sensitive to the. It should be noted that. It is our intention to generate, via ozone's direct. HIV, Hepatitis B, non- A. B (Hepatitis C). Anti- retroviral was. HUT- 7. 8 viability, as. Factor VIII biological activity, respectively. However, all. animals receiving similarly infected products without the. Medizone's contamination technology died within.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |